Global Pharmaceutical Secondary Packaging Market Research Report 2023

Publication ID:

PB504246818

Publication Date:

May 19, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Highlights
The global Pharmaceutical Secondary Packaging market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Pharmaceutical Secondary Packaging is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pharmaceutical Secondary Packaging is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Pharmaceutical Secondary Packaging in Ampoules is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Pharmaceutical Secondary Packaging include Catalent, Patheon, PCI Pharma Services, Pfizer CentreOne, Sharp, Almac Group, Central Pharma, CordenPharma and Eurofins CDMO, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Secondary Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Secondary Packaging.
The Pharmaceutical Secondary Packaging market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharmaceutical Secondary Packaging market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Secondary Packaging companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Catalent
Patheon
PCI Pharma Services
Pfizer CentreOne
Sharp
Almac Group
Central Pharma
CordenPharma
Eurofins CDMO
Tjoapack
ABS
Bushu Pharma
CMIC
Kishore group
Prince Art Packages
Segment by Type
Boxes
Cartons
Pouches
Others
Segment by Application
Ampoules
Blister Packs
Bottles
Cartridges
Syringes and Vials
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Secondary Packaging companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Secondary Packaging Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Boxes
1.2.3 Cartons
1.2.4 Pouches
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Secondary Packaging Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Ampoules
1.3.3 Blister Packs
1.3.4 Bottles
1.3.5 Cartridges
1.3.6 Syringes and Vials
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Secondary Packaging Market Perspective (2018-2029)
2.2 Pharmaceutical Secondary Packaging Growth Trends by Region
2.2.1 Global Pharmaceutical Secondary Packaging Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmaceutical Secondary Packaging Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical Secondary Packaging Forecasted Market Size by Region (2024-2029)
2.3 Pharmaceutical Secondary Packaging Market Dynamics
2.3.1 Pharmaceutical Secondary Packaging Industry Trends
2.3.2 Pharmaceutical Secondary Packaging Market Drivers
2.3.3 Pharmaceutical Secondary Packaging Market Challenges
2.3.4 Pharmaceutical Secondary Packaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Secondary Packaging Players by Revenue
3.1.1 Global Top Pharmaceutical Secondary Packaging Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical Secondary Packaging Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Secondary Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Secondary Packaging Revenue
3.4 Global Pharmaceutical Secondary Packaging Market Concentration Ratio
3.4.1 Global Pharmaceutical Secondary Packaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Secondary Packaging Revenue in 2022
3.5 Pharmaceutical Secondary Packaging Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Secondary Packaging Product Solution and Service
3.7 Date of Enter into Pharmaceutical Secondary Packaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Secondary Packaging Breakdown Data by Type
4.1 Global Pharmaceutical Secondary Packaging Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical Secondary Packaging Forecasted Market Size by Type (2024-2029)
5 Pharmaceutical Secondary Packaging Breakdown Data by Application
5.1 Global Pharmaceutical Secondary Packaging Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical Secondary Packaging Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical Secondary Packaging Market Size (2018-2029)
6.2 North America Pharmaceutical Secondary Packaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmaceutical Secondary Packaging Market Size by Country (2018-2023)
6.4 North America Pharmaceutical Secondary Packaging Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Secondary Packaging Market Size (2018-2029)
7.2 Europe Pharmaceutical Secondary Packaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmaceutical Secondary Packaging Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical Secondary Packaging Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Secondary Packaging Market Size (2018-2029)
8.2 Asia-Pacific Pharmaceutical Secondary Packaging Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmaceutical Secondary Packaging Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical Secondary Packaging Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Secondary Packaging Market Size (2018-2029)
9.2 Latin America Pharmaceutical Secondary Packaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmaceutical Secondary Packaging Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical Secondary Packaging Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Secondary Packaging Market Size (2018-2029)
10.2 Middle East & Africa Pharmaceutical Secondary Packaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmaceutical Secondary Packaging Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical Secondary Packaging Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Secondary Packaging Introduction
11.1.4 Catalent Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.1.5 Catalent Recent Development
11.2 Patheon
11.2.1 Patheon Company Detail
11.2.2 Patheon Business Overview
11.2.3 Patheon Pharmaceutical Secondary Packaging Introduction
11.2.4 Patheon Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.2.5 Patheon Recent Development
11.3 PCI Pharma Services
11.3.1 PCI Pharma Services Company Detail
11.3.2 PCI Pharma Services Business Overview
11.3.3 PCI Pharma Services Pharmaceutical Secondary Packaging Introduction
11.3.4 PCI Pharma Services Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.3.5 PCI Pharma Services Recent Development
11.4 Pfizer CentreOne
11.4.1 Pfizer CentreOne Company Detail
11.4.2 Pfizer CentreOne Business Overview
11.4.3 Pfizer CentreOne Pharmaceutical Secondary Packaging Introduction
11.4.4 Pfizer CentreOne Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.4.5 Pfizer CentreOne Recent Development
11.5 Sharp
11.5.1 Sharp Company Detail
11.5.2 Sharp Business Overview
11.5.3 Sharp Pharmaceutical Secondary Packaging Introduction
11.5.4 Sharp Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.5.5 Sharp Recent Development
11.6 Almac Group
11.6.1 Almac Group Company Detail
11.6.2 Almac Group Business Overview
11.6.3 Almac Group Pharmaceutical Secondary Packaging Introduction
11.6.4 Almac Group Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.6.5 Almac Group Recent Development
11.7 Central Pharma
11.7.1 Central Pharma Company Detail
11.7.2 Central Pharma Business Overview
11.7.3 Central Pharma Pharmaceutical Secondary Packaging Introduction
11.7.4 Central Pharma Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.7.5 Central Pharma Recent Development
11.8 CordenPharma
11.8.1 CordenPharma Company Detail
11.8.2 CordenPharma Business Overview
11.8.3 CordenPharma Pharmaceutical Secondary Packaging Introduction
11.8.4 CordenPharma Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.8.5 CordenPharma Recent Development
11.9 Eurofins CDMO
11.9.1 Eurofins CDMO Company Detail
11.9.2 Eurofins CDMO Business Overview
11.9.3 Eurofins CDMO Pharmaceutical Secondary Packaging Introduction
11.9.4 Eurofins CDMO Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.9.5 Eurofins CDMO Recent Development
11.10 Tjoapack
11.10.1 Tjoapack Company Detail
11.10.2 Tjoapack Business Overview
11.10.3 Tjoapack Pharmaceutical Secondary Packaging Introduction
11.10.4 Tjoapack Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.10.5 Tjoapack Recent Development
11.11 ABS
11.11.1 ABS Company Detail
11.11.2 ABS Business Overview
11.11.3 ABS Pharmaceutical Secondary Packaging Introduction
11.11.4 ABS Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.11.5 ABS Recent Development
11.12 Bushu Pharma
11.12.1 Bushu Pharma Company Detail
11.12.2 Bushu Pharma Business Overview
11.12.3 Bushu Pharma Pharmaceutical Secondary Packaging Introduction
11.12.4 Bushu Pharma Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.12.5 Bushu Pharma Recent Development
11.13 CMIC
11.13.1 CMIC Company Detail
11.13.2 CMIC Business Overview
11.13.3 CMIC Pharmaceutical Secondary Packaging Introduction
11.13.4 CMIC Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.13.5 CMIC Recent Development
11.14 Kishore group
11.14.1 Kishore group Company Detail
11.14.2 Kishore group Business Overview
11.14.3 Kishore group Pharmaceutical Secondary Packaging Introduction
11.14.4 Kishore group Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.14.5 Kishore group Recent Development
11.15 Prince Art Packages
11.15.1 Prince Art Packages Company Detail
11.15.2 Prince Art Packages Business Overview
11.15.3 Prince Art Packages Pharmaceutical Secondary Packaging Introduction
11.15.4 Prince Art Packages Revenue in Pharmaceutical Secondary Packaging Business (2018-2023)
11.15.5 Prince Art Packages Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Catalent
Patheon
PCI Pharma Services
Pfizer CentreOne
Sharp
Almac Group
Central Pharma
CordenPharma
Eurofins CDMO
Tjoapack
ABS
Bushu Pharma
CMIC
Kishore group
Prince Art Packages

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂